MultiStem
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction:
MultiStem is an adult, adherent, stem cell product, having shown safety and efficacy in other clinical…
MultiStem cells are clinical‐grade multipotent adult bone marrow‐derived progenitor cells (MAPCs), with extensive replication…
Stem cell therapy or “cell therapy” has been demonstrated to be a potent treatment intervention in animal models of acute…
Introduction: B01-02 was a double-blind, placebo-controlled study of ischemic stroke patients (NIHSS 8-20, inclusive) treated…
The translation of stem cell therapeutics, from experimental testing in preclinical animal models to clinical evaluation in human…
Background:
There is increasing evidence to suggest that some types of stem cells enhance recovery after stroke by exerting…
Athersys (Nasdaq: ATHX) is a biopharmaceutical company engaged in the discovery and development of novel therapies designed to…
Abstract 1987
Background. MultiStem®, a multipotent adult progenitor cells (MAPC) collection, is an immune-modulatory, bone…